Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Nov 8 - Nov 13
Tirzepatide Once Weekly for the Treatment of Obesity (June 4, 2022) MOUNJARO (tirzepatide) Injection, for subcutaneous use (2022) Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (May 11, 2025) Tirzepatide Once Weekly For The Treatment Of Obesity In People With Type 2 Diabetes (Surmount-2): A Double-Blind, Randomised, Multicentre, Placebo-Controlled, Phase 3 Trial (August 19, 2023) Efficacy And Safety Of A Novel Dual GIP And GLP-1 Receptor Agonist Tirzepatide In Patients With Type 2 Diabetes (Surpass-1): A Double-Blind, Randomised, Phase 3 Trial (July 10, 2021) Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (June 25, 2021) Zepbound (tirzepatide) Injection, for subcutaneous use (2022) The Risk Of Depression, Anxiety, And Suicidal Behavior In Patients With Obesity On Glucagon Like Peptide-1 Receptor Agonist Therapy (October 18, 2024)
The best choice depends on how the peptide will be used
Sermorelin What It Does: Sermorelin is a growth hormone releasing hormone (GH) that stimulates your pituitary gland to produce more natural growth hormone
Keeping food in the stomach longer keeps you full for longer
Biosynthetic human insulin and insulin analogs
US$ 27.09
US$ 22.43
US$ 29.08
US$ 25.60
